We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

PictureRx: An Intervention to Reduce Latino Health Disparities

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01618409
Recruitment Status : Completed
First Posted : June 13, 2012
Last Update Posted : June 13, 2012
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this randomized controlled trial is to evaluate the effect of Spanish-language illustrated medication instructions (PictureRx cards), compared to traditional medication instructions, on Latinos' understanding of their medication regimens. The study will also assess the effect on self-reported medication adherence. Patients with diabetes who attend participating clinics are eligible. The target sample size is 200.

Condition or disease Intervention/treatment
Medication Adherence Diabetes Behavioral: PictureRx card

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Health Services Research
Official Title: PictureRx: An Intervention to Reduce Latino Health Disparities
Study Start Date : March 2011
Primary Completion Date : December 2011
Study Completion Date : December 2011
Arms and Interventions

Arm Intervention/treatment
Experimental: PictureRx cards
Illustrated format of medication instructions that includes pictures of pills and icons to show their purpose
Behavioral: PictureRx card
An illustrated format of medication instructions that includes pictures of the medications and icons to illustrate their purpose
No Intervention: Control
Usual care

Outcome Measures

Primary Outcome Measures :
  1. Patient Understanding of their Medication Regimen [ Time Frame: Approximately 1 week after enrollment ]
    The primary outcome will be patients' understanding of their medication regimen, as assessed by an interviewer-administered questionnaire.

Secondary Outcome Measures :
  1. Self-reported Adherence [ Time Frame: Approximately 1 week after enrollment ]
    As a secondary outcome, patients will report their self-reported adherence using a validated instrument.

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Diabetes
  • Latino, Spanish speaker
  • Be at least 18 years old
  • Must be taking at least 1 chronic medication

Exclusion Criteria:

  • Too ill to participate in an interview
  • Do not have a telephone
  • Having visual acuity worse than 20/50 via Rosenbaum Visual Acuity exam (eyechart)
  • Inability to communicate in either Spanish or English
  • Overt psychiatric illnesses, overt delirium or dementia
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01618409

United States, Tennessee
Saint Thomas Family Health Center - South
Nashville, Tennessee, United States, 37211
Sponsors and Collaborators
PictureRx, LLC
National Institute on Minority Health and Health Disparities (NIMHD)
Principal Investigator: M Brian Riley, MA PictureRx, LLC
More Information

Responsible Party: M Brian Riley, Director of Research, PictureRx, LLC
ClinicalTrials.gov Identifier: NCT01618409     History of Changes
Other Study ID Numbers: 1R43MD004048 ( U.S. NIH Grant/Contract )
5R43MD004048-02 ( U.S. NIH Grant/Contract )
First Posted: June 13, 2012    Key Record Dates
Last Update Posted: June 13, 2012
Last Verified: June 2012

Keywords provided by M Brian Riley, PictureRx, LLC:
Health Literacy
Limited English Proficiency